BIOSPLICE THERAPEUTICS, INC.

Lobbying client · California · filed 2025 to 2026

Pharmaceutical company.

$240,000 Reported spend

4 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (69549), not by name.

Firms hired 1

AKIN GUMP STRAUSS HAUER & FELD $240,000 4 filings

Bills named in these filings 2

HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

1 filing
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

1 filing

Reported by year 2 years

2026 $180,000 2 filings
2025 $60,000 2 filings

Issues lobbied 1

Health Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 3
SENATE 3
Food & Drug Administration (FDA) 2
Health & Human Services, Dept of (HHS) 2
Executive Office of the President (EOP) 1
Office of Management & Budget (OMB) 1

Recent filings 4 total

Q2

AKIN GUMP STRAUSS HAUER & FELD

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $110,000 income · posted Jul 20, 2026

View → Q1

AKIN GUMP STRAUSS HAUER & FELD

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $70,000 income · posted Apr 20, 2026

View → Q4

AKIN GUMP STRAUSS HAUER & FELD

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → RR

AKIN GUMP STRAUSS HAUER & FELD

4th Quarter (Oct 1 - Dec 31) 2025 · posted Oct 27, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.